Zimmer Biomet (ZBH) PT Raised to $173 at Oppenheimer Ahead of Earnings
Tweet Send to a Friend
Oppenheimer analyst Steven Lichtman raised the price target on Zimmer Biomet (NYSE: ZBH) to $173.00 (from $155.00) ahead of 4Q20 ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
